The FDA has authorized the emergency use of nirmatrelvir-ritonavir (Paxlovid) for people who aren't seriously ill with COVID-19, but who have a higher risk of becoming seriously ill from the virus. The CDC identifies numerous risk factors that make someone eligible for Paxlovid treatment, including the following:
• Age 65 or over (if you're vaccinated against COVID-19)
• Age 50 or over (if you're not vaccinated against COVID-19)
• BMI 30 or higher (obesity)
• Physical inactivity (sedentary lifestyle)
• Current use or former regular use of tobacco products
• Pregnancy or recent pregnancy (in the last 6 weeks)
You may also qualify for treatment if you have an underlying health condition, including one of the following:
• Cancer, HIV, or a weakened immune system
• Chronic kidney disease (with eGFR above 30mL/min)
• Parkinson’s disease or dementia
• Disability that makes it difficult to do certain activities or interact with the world around you, including Down syndrome, ADHD, autism, and physical disabilities
• Heart condition like heart failure, coronary artery disease (CAD), or arrhythmia (irregular heartbeat)
• Mental health condition like depression or schizophrenia
• Sickle cell disease or thalassemia
• History of stroke, TIA, or cerebrovascular disease
• Substance use disorder (drugs or alcohol)